Resveratrol: all 134 studies that test it

Page 1 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol SupplementationRecruitingNCT07865377Not applicable
• RESvEraTrol in Parkinson's Disease (RESET)RecruitingNCT07592767Phase 2
• Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen PlanusRecruitingNCT07100613Phase 2
• Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face StudyNot yet recruitingNCT07060157Not applicable
• Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.RecruitingNCT06882564Phase 3
• Strength Training and ResveratrolRecruitingNCT06585865Not applicable
• Effects of Resveratrol Supplementation on Oocyte QualityNot yet recruitingNCT06235294Not applicable
• The Effects of Resveratrol on Sirtuins and Apoptosis BiomarkersRecruitingNCT05808387Not applicable
• Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1RecruitingNCT04449198Early Phase 1
• Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19TerminatedNCT04400890Phase 2Results posted
• Resveratrol Trial for Relief of Pain in PseudoachondroplasiaTerminatedNCT03866200Phase 2Results posted
• Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery DiseaseCompletedNCT03743636Phase 3Results posted
• Resveratrol and Vascular Function in CKDCompletedNCT03597568Not applicableResults posted
• Estrogen and DiabetesCompletedNCT03436992Not applicableResults posted
• Resveratrol and Sirolimus in Lymphangioleiomyomatosis TrialCompletedNCT03253913Phase 2Results posted
• Effects of Botanical Microglia Modulators in Gulf War IllnessCompletedNCT02909686Not applicableResults posted
• Resveratrol and Exercise to Treat Functional Limitations in Late LifeCompletedNCT02523274Phase 2Results posted
• Resveratrol for Pain Due to EndometriosisCompletedNCT02475564Phase 4Results posted
• The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal WomenCompletedNCT02256540Not applicableResults posted
• RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)CompletedNCT02246660Not applicableResults posted
• Resveratrol to Enhance Vitality and Vigor in EldersCompletedNCT02123121Phase 2Results posted
• Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin SecretionCompletedNCT02114892Phase 2Results posted
• Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 YearsCompletedNCT01668836Not applicableResults posted
• Chronic Resveratrol Supplementation in Healthy HumansCompletedNCT01640197Phase 1Results posted
• Resveratrol for Alzheimer's DiseaseCompletedNCT01504854Phase 2Results posted
• Pilot Study of Resveratrol in Older Adults With Impaired Glucose ToleranceCompletedNCT01375959Not applicableResults posted
• Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in HumansCompletedNCT01354977Phase 2Results posted
• Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in BoxersCompletedNCT01321151Phase 1/2Results posted
• The Cognitive and Cerebral Blood Flow Effects of ResveratrolCompletedNCT01010009Not applicableResults posted
• A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple MyelomaTerminatedNCT00920556Phase 2Results posted
• Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 DiabetesCompletedNCT07569744Not applicable
• Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin ResistanceCompletedNCT06961279Not applicable
• Study of High-Dose Resveratrol in Patients With Stable Ischemic Heart DiseaseCompletedNCT06914934Not applicable
• Resveratrol for the Prevention of Bone Loss in Postmenopausal WomenCompletedNCT06250283Not applicable
• Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With NeuropathyCompletedNCT06131918Phase 2
• Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOSCompletedNCT05653895Not applicable
• Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction TrialStatus unknownNCT05500742Not applicable
• Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian InsufficiencyStatus unknownNCT05410093Not applicable
• Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWICompletedNCT05377242Not applicable
• Effect of Resveratrol and Pharmacist Intervention on Diabetes Mellitus and Its Neuropathic ComplicationCompletedNCT05172947Not applicable
• A Study to Evaluate the Safety and Efficacy of RQC for AMDCompletedNCT05062486Phase 2
• Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian SyndromeCompletedNCT04867252Phase 2
• The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 PatientsStatus unknownNCT04799743Not applicable
• Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc TherapyTerminatedNCT04542993Phase 2
• Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)CompletedNCT04421079Phase 1
• Biological Effects of Treatment With Resveratrol in ART PatientsCompletedNCT04386499Not applicable
• The Effects of Resveratrol Supplementation on Inflammation and Cognitive Performance in Healthy AdultsCompletedNCT04314739Not applicable
• Effect of Resveratrol on Serum IGF2 Among African American WomenWithdrawnNCT04266353Not applicable
• Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic FibrosisCompletedNCT04166396Early Phase 1
• Micronised Resveratrol as a Treatment for Friedreich AtaxiaCompletedNCT03933163Phase 2
• Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT03819517Early Phase 1
• Short Interval Resveratrol Trial in Cardiovascular SurgeryActive, not recruitingNCT03762096Not applicable
• Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation DisordersCompletedNCT03728777Not applicable
• Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)Status unknownNCT03665740Phase 2
• The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT03546530Not applicable
• The Impact of Acute Trans-resveratrol Administration on Whole Body Metabolism During Cognitive Demand.CompletedNCT03546075Not applicable
• The Cerebral Hemodynamic and Cognitive Effects of Acute Resveratrol Administration in Young, Healthy Adults at Stimulated Altitude.CompletedNCT03541993Not applicable
• Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart FailureCompletedNCT03525379Phase 2
• The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical TrialCompletedNCT03509688Not applicable
• The Effects of Resveratrol Supplementation on Cognition, Cerebral Blood Flow, Microbiota and Systemic Inflammation.CompletedNCT03448094Not applicable
• Resveratrol as a Preventive Treatment of OHSSCompletedNCT03446625Phase 3
• The Effects of Resveratrol on the Complications of Patients With HemodialysisCompletedNCT03352895Not applicable
• Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans.CompletedNCT03100019Not applicable
• Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mgCompletedNCT03097211Phase 1
• Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young SubjectsCompletedNCT03095105Phase 1
• Effect of Food on BIA 6-512 (Trans-resveratrol)CompletedNCT03095092Phase 1
• Effect of BIA 6-512 at Steady-state on the Levodopa PharmacokineticsCompletedNCT03094156Phase 1
• Tolerability and Steady-state Pharmacokinetics of BIA 6-512CompletedNCT03093389Phase 1
• Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa PharmacokineticsCompletedNCT03091868Phase 1
• Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa PharmacokineticsCompletedNCT03091543Phase 1
• Effect of Resveratrol and Vitamin C on Insulin Resistance Among Postmenopausal WomenStatus unknownNCT03090997Not applicable
• Oral Resveratrol to Prevent Post-ERCP PancreatitisStatus unknownNCT02947932Phase 4
• Resveratrol in Knee OsteoarthritisCompletedNCT02905799Phase 3
• Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) PatientsStatus unknownNCT02766803Phase 4
• Resveratrol's Effects in Diabetic NephropathyCompletedNCT02704494Early Phase 1
• Resveratrol for Exudative Age-Related Macular DegenerationTerminatedNCT02625376Not applicable
• Effects of Trans-Resveratrol in Endothelial Function in Hypertensive PatientsCompletedNCT02616822Phase 1
• Long-term Resveratrol and MetabolismCompletedNCT02565979Not applicable
• Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes MellitusTerminatedNCT02549924Phase 2
• Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney DiseaseCompletedNCT02433925Phase 3
• Resveratrol and Huntington DiseaseCompletedNCT02336633Not applicable
• Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and BloodStatus unknownNCT02321176Not applicable
• Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5CompletedNCT02314208Phase 2
• Resveratrol and Human Hepatocyte Function in CancerWithdrawnNCT02261844Phase 1/2
• Effects of High-Dose Resveratrol in Non-Diabetic Obese MalesCompletedNCT02247596Phase 2
• Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)CompletedNCT02245932Not applicable
• Effects of Resveratrol on Inflammation in Type 2 Diabetic PatientsCompletedNCT02244879Phase 3
• Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid PeroxidationCompletedNCT02219906Not applicable
• Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight AdolescentsCompletedNCT02216552Phase 2/3
• A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic SyndromeCompletedNCT02137421Not applicable
• Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic RhinitisCompletedNCT02130440Phase 3
• Resveratrol and First-degree Relatives of Type 2 Diabetic PatientsCompletedNCT02129595Not applicable
• Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With SchizophreniaCompletedNCT02062190Phase 2
• The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic SteatohepatitisCompletedNCT02030977Phase 2/3
• Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?Status unknownNCT01997762Phase 4
• Effect of Antioxidant Intake on Cardiovascular RiskCompletedNCT01964846Not applicable
• Effects of Resveratrol on Endothelial Function in Type 2 Diabetes MellitusCompletedNCT01881347Not applicable
• Resveratrol and Cardiovascular Health in the ElderlyTerminatedNCT01842399Phase 1/2
• Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass SurgeryStatus unknownNCT01826279Not applicable
• Cognitive Effects of 500mg Trans-resveratrolCompletedNCT01794351Not applicable

← Resveratrol overview